secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0000950170-23-007317
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta reports <5% cash held at SVB; no material impact on runway
-----------------------------------------------------------------

- Less than ~5% of Enanta's cash and marketable securities were in Silicon Valley Bank operating accounts.
- Remaining investments held in custody accounts at an independent institution.
- No material impact on projected cash runway or operations from SVB exposure.
- Disclosure made on March 10, 2023 amid SVB liquidity crisis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000095017023007317/0000950170-23-007317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000095017023007317/enta-20230310.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer